Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
As seen in:  Forbes

Forbes reporter covering science and medicine

Cancer Killed A Google Executive's Wife. He Thinks His New Startup Might Have Saved Her

forbes.com — Jeff Huber Jeff Huber, who helped lead the development of Google's ad software and its iconic maps application will be the chief executive of Grail, a startup that raised $100 million last month to create a blood test to detect cancer early, when it is treatable. His reasons are scientific, but also personal.
Feb 10, 2016

The new CEO of $ILMN's Grail lost his wife to cancer. He thinks his new company might have saved her. forbes.com/sites/matthewh…

Feb 10, 2016

I'm going to tweet my profile of new Grail CEO @jhuber 1 more time, because it's a sad story, and a hopeful one. forbes.com/sites/matthewh…

Here Are Some Solutions To The Martin Shkreli Problem

forbes.com — There was no doubt that hauling Martin Shkreli, the infamous young pharmaceutical entrepreneur, in front of Congress would be dramatic. Of course it was. But did it get us any closer to preventing the next Martin Shkreli from taking an old drug and raising the price 5,000%?
Feb 04, 2016

RT @amitabhchandra2: Congress, for its part, showed itself to be full of ignorance about how the medical system and pharmaceuticals work forbes.com/sites/matthewh…

Feb 04, 2016

RT @amitabhchandra2: Congress, for its part, showed itself to be full of ignorance about how the medical system and pharmaceuticals work forbes.com/sites/matthewh…

Feb 04, 2016

RT @amitabhchandra2: Congress, for its part, showed itself to be full of ignorance about how the medical system and pharmaceuticals work forbes.com/sites/matthewh…

Show 2 more tweets from Jason Gale, Jason Gale

The Peculiar Brilliance Of Donald Trump's Healthcare Strategy

forbes.com — Ted Cruz is on the attack. In an ad running in Iowa ahead of today's caucus - the first battle of this year's presidential primary - Cruz uses Trump's own words to compare the Donald to Hillary and Obama. HillaryCare, ObamaCare, TrumpCare, it's all the same thing, Cruz implies: a [...]
Feb 01, 2016

OK. Deleted my confused tweet about hearing timing. Read my story on Trump instead. forbes.com/sites/matthewh…

Some Theranos Tests "Pose Immediate Jeopardy To Patient Health And Safety"

Jan 27, 2016

U.S. Regulators: Some Theranos Tests "Pose Immediate Jeopardy To Patient Health And Safety" forbes.com/sites/matthewh…

Jan 27, 2016

U.S. Regulators: Some Theranos Tests "Pose Immediate Jeopardy To Patient Health And Safety" via @forbes forbes.com/sites/matthewh…

Jan 27, 2016

RT @matthewherper: U.S. Regulators: Some Theranos Tests "Pose Immediate Jeopardy To Patient Health And Safety" via @forbes forbes.com/sites/matthewh…

Jan 27, 2016

RT @KerryDolan: U.S. Regulators: Some #Theranos Tests 'Pose Immediate Jeopardy To Patient Health&Safety' via @forbes @matthewherper https:/…

The Health Care Delusion Hillary And Trump Share

forbes.com — When it comes to healthcare, Hillary Clinton and Donald Trump should be miles apart. Clinton is a Democrat, Trump a Republican. Clinton is a wonk who spent years putting together punctilious policy prescriptions, even heading a failed healthcare overhaul during her husband's presidential administration. Trump is a dilettante who has [...]

Is There Hope For Sarepta Therapeutics? Yes, A Bit

forbes.com — Given different weather, Cambridge, Mass.-based Sarepta Therapeutics's n would be most of the way through running a gauntlet of Food and Drug Administration advisors at a public meeting. But that meeting has been been postponed, probably for weeks, due to the impending snowpocalypse. So maybe it's worth me putting some thoughts [...]

Solving Pharma's Shkreli Problem

forbes.com — The most hated entrepreneur in America did a public service in some ways: He revealed a fundamentally flawed system that threatens an entire industry.
Jan 20, 2016

"the industry’s dirty little secret is that it is full of Martin Shkrelis, albeit less greedy ones" : forbes.com/sites/matthewh… #pharma

Jan 20, 2016

Ridiculously easy to raise Rx price without depressing sales. Super piece: forbes.com/sites/matthewh…

Jan 20, 2016

Your morning must-read: @matthewherper on solving pharma's Shkreli problem. forbes.com/sites/matthewh…

Show 21 more tweets from Charles Ornstein, Laura Helmuth and others...

The Problem With The New Breast Cancer Screening Recommendations

forbes.com — As a doctor, I am charged with improving and protecting the health of my patients. No one doubts my mandate. But a Washington task force is doing its level best to make the job harder and jeopardize the lives of women.
Jan 20, 2016

RT @tiffanyarment: The Problem With The New Breast Cancer Screening Recommendations via @forbes forbes.com/sites/matthewh…

7 Thoughts On Today's Pharma & Biotech News

forbes.com — Seven thoughts: Shire's purchase of Baxalta is emblematic of the shift in the drug industry. The company that popularized Adderall and help market the diagnosis of ADHD is now focused almost entirely on pricey, rare diseases, with an option on cancer. Vertex and Illumina both released relatively weak financial forecasts ahead of [...]

A Single Blood Test For All Cancers? Illumina, Bill Gates and Jeff Bezos Launch Startup To Make It Happen

forbes.com — Illumina CEO Jay Flatley What if a simple blood test could detect any cancer early, when it was still easy to treat? It sounds like science fiction. But Illumina, the $24 billion (market cap) biotechnology company that has pioneered cheap, efficient sequencing of DNA, says it could be a reality in a [...]
Jan 10, 2016

RT @JohnNosta: 1 Blood Test For All Cancers? Illumina, Bill Gates and Jeff Bezos Launch Startup To Make It Happen! #digitalhealth forbes.com/sites/matthewh…

More Articles →
Feb 10, 2016

I'm going to tweet my profile of new Grail CEO @jhuber 1 more time, because it's a sad story, and a hopeful one. forbes.com/sites/matthewh…

Feb 10, 2016

RT @cbwang: Excited to announce Jeff Huber (@jhuber) appointed CEO of @GrailBio; @MatthewHerper tells Jeff's personal story: onforb.es/1TSd0nV

Feb 10, 2016

@sesiegler This is different: they're not selling anything, and it's news that these people are putting money here.

Feb 10, 2016

@Liquid_Biopsy @sesiegler Like I said, there's no data. This story is worthy of attention solely because of the team involved and $$$.

Feb 10, 2016

Compounder Imprimis to version of $RTRX's Thiola -- the first drug for which @MartinShkreli increased the price. imprimispharma.investorroom.com/2016-02-10-Imp…

Feb 10, 2016

The new CEO of $ILMN's Grail lost his wife to cancer. He thinks his new company might have saved her. forbes.com/sites/matthewh…


Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.